MedQuist, SEC Settle; Execs Still On Hook For Fraud

Law360, New York (March 13, 2009, 12:00 AM EDT) -- The U.S. Securities and Exchange Commission on Thursday settled two suits with medical transcription company MedQuist Inc. and a former executive, and filed a third suit alleging that two former executives committed fraud and violated other federal securities laws by overcharging customers.

MedQuist has agreed to be permanently enjoined from violating the federal securities laws' antifraud, reporting, internal controls and books and records provisions, the SEC said in a statement Thursday. Medquist and its former Chief Operating Officer, John A. Donohoe, do not admit or deny...
To view the full article, register now.